Mehmet Oz is pledging to divest from a broad portfolio of health care stocks if he is confirmed as President Trump’s pick to lead the Centers for Medicare and Medicaid Services.

The assurances in an ethics filing from Dr. Oz, a medical TV personality, are designed to avoid conflicts of interest at CMS, which oversees the insurance programs that interact with hospitals and other medical providers.

He vowed to divest within 90 days of his confirmation from companies like HCA Healthcare and United Health Group, drugmakers Abbvie and Eli Lilly and retail behemoths like Walmart and Amazon, which dabble in health care.

Dr. Oz, 64, built his name and brand as a frequent guest on “The Oprah Winfrey Show” and “The Dr. Oz Show” on television. He developed a relationship with Mr. Trump during his TV years and the COVID-19 crisis. Also, he ran unsuccessfully for a U.S. Senate seat from Pennsylvania in 2022.

Mr. Trump appointed Dr. Oz to run CMS, which oversees programs like Medicare and Medicaid, though he must be confirmed by the Senate.

Dr. Oz’s ethics filing, dated Feb. 16, says he would resign from various endorsement and advisory roles, including from iHerb LLC, a nutritional supplement company, and EKO Health Inc., a company developing a digital stethoscope.

Dr. Oz said he will continue to have a financial interest in Emerald Oaks, a cattle ranch in Florida, though will “receive only passive investment income from it” and not participate in decisions that could impact its finances.

The son of Turkish immigrants, Dr. Oz said he has four residential properties in Turkey with his family.

“I will continue to have a financial interest in these properties, but I will not provide services material to the production of income,” he said.

• Tom Howell Jr. can be reached at thowell@washingtontimes.com.